Experts break down regulatory issues in 30 minutes or less.
October 11, 2023
It may surprise some to know that the government has definitive racial classifications for Americans, and it can be still…
Listen to this podcastJuly 31, 2023
The debate over the electrification agenda and its implications for consumer choice and the environment remains contentious. As federal agencies…
Listen to this podcastJuly 21, 2023
Affirmative action plans, though perhaps most associated with college admissions and higher education, actually crop up in a wide array…
Listen to this podcastJune 12, 2023
On June 13, 2013, the Supreme Court issued its unanimous decision in Association for Molecular Pathology v. Myriad Genetics Inc….
Listen to this podcastMay 24, 2023
On April 6, 2023, the Biden Administration announced two new efforts to “modernize regulatory review” – the first through the…
Listen to this podcastMay 16, 2023
Biosimilars, a category of biologic (medicine derived from a living organism), require approval, at least in the U.S. by the…
Listen to this podcastMarch 8, 2023
In late February 2023, the FDA released its responses to the December 2022 Regan-Udall Foundation reports on the FDA’s Human Foods and Tobacco programs.
Listen to this podcastMarch 7, 2023
In this podcast featuring Tom Miller, he lays out a brief summary of how we got to where we are with regards to Medicaid.
Listen to this podcastFebruary 17, 2023
Last November, the Federal Trade Commission accepted comments on its proposal to start a rulemaking related to “Commercial Surveillance” – the agency’s newly minted term for any and all business use of data about customers.
Listen to this podcastFebruary 8, 2023
Energy consumers continue to see rising rates, but how do regulators decide the rate that consumers pay? In this episode, James Coleman and Mark Ellis explain the relationship between federal and state regulators and utility companies, the financing models behind regulated rates, and the incentives created by these models.
Listen to this podcast